Greek doctor Dr Evangelos Michelakis is at the forefront of mitochondrial research at Alberta Medical University in Edmonton, Canada where he is co-head of a study aiming to fight Pulmonary Arterial Hypertension (PAH) by means of a new drug which targets mitochondria.